Studies on the sensitivity of Plasmodium falciparum to pyronaridine / sulfadoxine / pyrimethamine in vitro

u6076u6027u759fu539fu866bu5bf9u54afu8418u5576/ u78fau80fa u591au8f9b/u4e59u80fau5627u5576u654fu611fu6027u4f53u5916u6d4bu5b9au65b9u6cd5u7684u7814u7a76

Combined use of pyronaridine sulfadoxine and primaquine in areas with chloroquine - resistant falciparum malaria

u78f7u9178u54afu8418u5576u4e0e u78fau80fa u591au8f9bu3001u4f2fu55b9u4f0du7528u5728u6297u6c2fu55b9u5730u533au6cbbu7597u6076u6027u759fu7684u89c2u5bdf

They were treated with either chloroquine or a combination of sulfadoxine and pryrimethamine .

u4ed6u4eecu6216u8005u670du7528u4e86u6c2fu55b9uff0cu6216u8005u8054u5408u670du7528u4e86 u78fau80fa u591au8f9bu548cpryrimethamineu3002

Analysis on results of antimalarial pyronaridine combined with sulfadoxine and pyrimethamine to falciparum malaria

u6297u759fu836fu54afu8418u5576u4e0e u78fau80fa u591au8f9bu53cau4e59u80fau5627u5576 u914du4f0du6cbbu7597u6076u6027u759fu7ed3u679cu7684u5206u6790

Comparative studies on the treatment of drug resistant falciparum malaria with single dose or two day regimens of pyronaridine / sulfadoxine pyrimethamine plus primaquine

u54afu8418u5576u4e0e u78fau80fa u591au8f9b -u4e59u80fau5627u5576u5355u5242u53cau4e24u5929u7597u6cd5u52a0u4f2fu6c28u55b9u6cbbu7597u6076u6027u759fu7684u6548u679c

The susceptibility of this chloroquine-resistant line to 7 antimalarials revealed more sensitive to pyrimethamine sulfadoxine and primaquine but exhibited some degree of cross resistance to the other 4 drugs i. e.

u5bf97u79cdu5e38u7528u6297u759fu836fu654fu611fu6027u6d4bu8bd5u7684u7ed3u679cu8868u660euff0cu8be5u7cfb u9664u5bf9u4e59u80fau5627u5576u3001 u5468 u6548 u78fau80fau548cu4f2fu55b9u654fu611f u5916uff0cu5bf9u53e6u59164u79cdu836fu7269u5747u663eu793au51fau7a0bu5ea6 u4e0du7b49u7684u4ea4u53c9u6297u836fu6027u3002